From $10bn to prison: The rise and fall of Theranos founder Elizabeth Holmes
Theranos founder Elizabeth Holmes, 37, faced four counts of defrauding investors. The charges carry a maximum prison term of 20 years each.
2010 - Theranos raises a further $45 million in funding, reaching a valuation of $1 billion.
2011 - Theranos begins attracting high-profile board members, including two former U.S. secretaries of state, George Shultz and Henry Kissinger.
2012 - The company moves to the former Facebook headquarters in Palo Alto, California.
2013 - Theranos begins promoting its technology, claiming to be able to run a wide range of tests on a single drop of blood using a machine called the Edison, and enters into a partnership with Walgreens Boots Alliance.
2014 - Having raised more than $400 million, the company is valued at more than $9 billion. Holmes is recognized by Forbes as a billionaire, thanks to her stake in the company.
February 2015 - An article in the Journal of the American Medical Association criticizes Theranos for failing to publish any of its research in peer-reviewed journals.
July 2015 - Theranos wins U.S. Food and Drug Administration approval for a test to detect the herpes simplex 1 virus.
October 2015 - The Wall Street Journal reports that Theranos uses its technology for only a small number of its tests, and that employees doubt their accuracy. The FDA subsequently releases a finding that the company used unapproved devices for tests.
January 2016 - The U.S. Centers for Medicare & Medicaid Services (CMS) releases a report that one of the company's facilities presents "jeopardy to patient health and safety." The agency said an inspection revealed that the facility did not meet its own quality-control standards, including not properly calibrating equipment.
June 2016 - Walgreens ends its relationship with Theranos.
October 2016 - Partner Fund Management, which invested nearly $100 million in Theranos, sues the company for securities fraud, claiming it lied about its technology to secure the investment. The case is later settled.
April 2017 - Theranos reaches a deal with CMS barring it from the blood-testing business for two years.
March 2018 - The U.S. Securities and Exchange Commission charges Theranos, Holmes and Balwani with securities fraud. Holmes is stripped of her stake in and control of the company.
- Advertisement -